The Current

Diamond Sports ruling signals new era for local NBA, MLB, NHL streaming rights

View news
South China Morning Post

Chinese biotech firms brace for profit hit from Trump tariffs, US funding bill

View news
The Times

Can Pascal Soriot contain the China crisis at AstraZeneca (Subscription required)

View news
CNN Business

Stores don’t sell your favorite product anymore. That’s on purpose

View news
Financial Times

AstraZeneca shares fall as China probe intensifies (Subscription required)

View news
The Wire China

Big Pharma Doubles Down on China

View news
STAT logo

VCs move to launch U.S.-based companies to advance drugs developed in China (Subscription required)

View news
CFNews

Jean-Philippe Grosmaitre et Claudio Molinaro “La performance et la transformation opérationnelle permettent de créer une valeur durable”

 

 

 

 

View Transcript and News
Valor international

EMS-Hypera merger could spark new wave of consolidation

View news
Bloomberg

US Venture Capital Opens Path to Funding for China Biotech Firms (Subscription required)

View news
Pet Food Processing

Survey: Consumers more interested in sustainable pet foods

View news
SCI logo

New UK Industrial Strategy coming soon, says Chancellor

View news
PharmExec.com

Outsourcing’s Evolution in the Pharma Industry

View news

China opens up healthcare sector to foreign investment in major policy shift (Subscription required)

View news
The Times

AstraZeneca reaches for the stars with its Shanghai partner

View news
Pink Sheet

Clinical Trials In China: As US Lawmakers Consider Crackdown, Here Are The Implications

View news
MedCity News

The Surprising Rivalries-Turned-Friendships That Are Shaping Diabetes Technology

View news
Fierce Pharma

UCB sells off production plant and a clutch of older meds in China for $680M

View news
The Wire China

China's Ozempic Test

View news
Grocery Dive

Grocers are looking beyond prescription sales to succeed with in-store pharmacies

View news
Mergermarket

European industrials and chemicals dealmakers concentrate on consolidation homework – Trendspotter

View news
Directors & Boards

The Case for the Executive Chair

View news
The Standard

Drug firms slow to cut China ties

View news
Bloomberg

Companies Hold Back on Cutting China Ties Ahead of Biosecure Act (Subscription required)

View news
Hospital and Healthcare

Funding for six digital health tech companies

View news